NCT06665321|Not Yet Recruiting
Loading search results
Sponsor study identifier
interventional
108
1 country
1
Study Start
January 2025
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Primary Completion
April 2025
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Study Completion
June 2025
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
The purpose of the study is to investigate if internet delivered affect-focused psychodynamic therapy (IPDT) leads to lowered levels of trait neuroticism compared to a wait-list control condition. The target group is adults (18+) who experience mild to moderate symptoms of anxiety and/or depression. The IPDT treatment consists of 8 modules that the participants will work with for 9 weeks, with therapist support. Participants will be recruited in Sweden with nationwide recruitment.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
June 2025
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
October 29, 2024
Actual (reported)October 30, 2024
Actual (reported)January 2025
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
April 2025
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
June 2025
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Neuroticism scale of the Maples et al (2014) IPIP NEO PI 120 Item representation
Measure of trait neuroticism. Consists of 24 items. Each item is scored from 0-4 with a total range of 0-96. A higher score reflects a higher level of trait neuroticism.
Change between baseline, end of treatment after nine weeks and follow-up at 12 months after treatment termination.
Eysenck Personality Questionnaire Revised - Shortform (EPQR-S)
Change between baseline, end of treatment after nine weeks and follow-up at 12 months after treatment termination.
Patient Health Questionnaire-9
Change between baseline, end of treatment after nine weeks and follow-up at 12 months after treatment termination.
Generalized Anxiety Disorder-7
Change between baseline, end of treatment after nine weeks and follow-up at 12 months after treatment termination.
Brunnsviken Brief Quality of life scale
Change between baseline, end of treatment after nine weeks and follow-up at 12 months after treatment termination.
Difficulties in Emotion Regulation Scale-16
Change between baseline, end of treatment after nine weeks and follow-up at 12 months after treatment termination. Will be measured on a weekly basis during the 9 weeks of the intervention period.
The treatment consist of a 9 week long IPDT intervention based on Affect Phobia Therapy with weekly therapist support.
Wait-list control condition, participants have the option to contact the treatment team in case of worsened symptoms.
The intervention is 9 week long with weekly modules that the participants work with while receiving weekly support from an assigned therapist.
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Department of Behavioral Sciences and Learning
Linköping, Östergörland, 58183, Sweden
Gerhard Andersson, PhD
Linkoeping University
First Submitted
October 29, 2024
First Posted
October 30, 2024
Study Start
January 2025
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Contact the study team to confirm eligibility.
Primary Completion
April 2025
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Study Completion
June 2025
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Last Updated
November 12, 2024
Record last verified: 2024-10
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: